Part 15 Research and Development

Part 15 Research and Development

Rates of relief

112

(1)     In relation to expenditure incurred before 1 August 2008, Part 13 has effect with the following modifications.

(2)     In Chapter 2 (relief for SMEs: cost of R&D incurred by SME)—

(a)     in section 1044(8), for “75%†substitute “50%â€,

(b)     in section 1045(7), for “175%†substitute “150%â€,

(c)     in section 1055(2)(b), for “175%†substitute “150%â€, and

(d)     in section 1058(1)(a), for “14%†substitute “16%â€.

(3)     In Chapter 7 (relief for SMEs and large companies: vaccine research etc)—

(a)     in section 1089(2), for “40%†substitute “50%â€,

(b)     in section 1090(2), for “40%†substitute “50%â€,

(c)     in section 1091—

(i)     in subsection (3), for “40%†substitute “50%â€, and

(ii)     in subsection (4), for “140%†substitute “150%â€,

(d)     in section 1092(8)—

(i)     in paragraph (a), for “40%†substitute “50%â€, and

(ii)     in paragraph (b), for “140%†substitute “150%â€, and

(e)     in section 1104(5), for “140%†substitute “150%â€.

R&D threshold in section 1050: qualifying Chapter 3 and 4 expenditure

113

(1)     The references in section 1050(3)(b) and (c) to qualifying Chapter 3 expenditure and qualifying Chapter 4 expenditure do not include any such expenditure incurred before 1

Powered by Lexis+®

Popular documents